Aclarion News - ACON

Company Name	Stock Ticker Symbol	Market	Type
Aclarion Inc	ACON	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.0%	0.27	19:04:42

Open Price	Low Price	High Price	Close Price	Prev Close
0.2891	0.26	0.2891	0.27	0.27

more quote information »

Recent News

Date	Time	Source	Heading
11/27/2023	08:00	GLOBE	Aclarion Announces Key Commercial Milestone With Completion..
11/22/2023	16:01	EDGAR2	Form 8-K - Current report
11/16/2023	16:58	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/13/2023	06:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/08/2023	08:00	GLOBE	Aclarion Announces Achievement of Goal to Enroll 10 Leading..
11/06/2023	08:00	GLOBE	Aclarion Expands Immediate Nociscan Access Into New York..
11/01/2023	16:15	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/01/2023	08:00	GLOBE	Aclarion Presents at the NIH HEAL Initiative Fall Meeting
10/30/2023	17:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
10/25/2023	08:30	GLOBE	Aclarion Announces Signing of Commercial Agreement With..
10/24/2023	08:45	GLOBE	Aclarion Announces Nociscan® Cost-Effectiveness Poster..
10/23/2023	08:55	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/23/2023	07:00	GLOBE	Aclarion Announces Signing Strategic Partnership Letter of..
10/23/2023	06:00	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/23/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
10/20/2023	15:08	EDGAR2	Form S-1/A - General form for registration of securities..
10/10/2023	15:34	EDGAR2	Form S-1 - General form for registration of securities under..
10/10/2023	08:30	EDGAR2	Form 8-K - Current report
10/02/2023	08:00	GLOBE	Aclarion Provides Updated Investor Presentation and..
9/28/2023	07:48	EDGAR2	Form 8-K - Current report
9/07/2023	16:01	EDGAR2	Form 8-K - Current report
8/31/2023	16:01	EDGAR2	Form 8-K - Current report
8/25/2023	16:42	EDGAR2	Form 8-K - Current report
8/25/2023	16:10	GLOBE	Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly..
8/25/2023	13:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	16:30	EDGAR2	Form 8-K - Current report
8/14/2023	16:27	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
8/10/2023	17:12	EDGAR2	Form 8-K - Current report
7/14/2023	16:58	EDGAR2	Form 8-K - Current report
7/14/2023	16:06	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
7/12/2023	17:27	EDGAR2	Form S-1/A - General form for registration of securities..
7/07/2023	16:01	EDGAR2	Form 8-K - Current report
7/03/2023	16:01	EDGAR2	Form S-1 - General form for registration of securities under..
7/03/2023	08:13	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/14/2023	11:27	GLOBE	Aclarion Announces New Commercial Engagement with The..
6/08/2023	07:30	GLOBE	Aclarion Announces Statistically Significant Nociscan®..
5/30/2023	07:30	GLOBE	Aclarion Announces New Engagement with The London Clinic and..
5/23/2023	07:30	GLOBE	Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon..
5/23/2023	07:00	GLOBE	Aclarion, Inc. Announces Delayed 10-Q Filing
5/19/2023	07:30	GLOBE	Aclarion Announces Non-Convertible Debt Financing to Achieve..
5/02/2023	07:00	GLOBE	Aclarion Appoints Nicholas Theodore, MD as Principal..
4/28/2023	11:20	GLOBE	Aclarion to Host Thought Leadership Symposium at SPINEWEEK..
4/24/2023	07:00	GLOBE	Aclarion Announces Publication of 2YR Outcomes in..
3/07/2023	09:19	GLOBE	Aclarion Announces Alpesh Patel MD MBA as a Key Opinion..
2/15/2023	07:00	GLOBE	Aclarion Supports Thought Leadership at the 2nd Annual..
1/31/2023	10:01	GLOBE	Gregory Basil MD to Join Aclarion as a Key Opinion Leader..
1/17/2023	08:29	GLOBE	Aclarion Appoints George Frey MD as Seventh Key Opinion..
12/22/2022	10:36	GLOBE	Dr. Christopher Ames to Join Aclarion as a Key Opinion..
12/21/2022	10:23	GLOBE	Aclarion’s Key Opinion Leader Program Adds Fifth Surgeon..
12/19/2022	08:33	GLOBE	Aclarion Adds to Growing Key Opinion Leader Program with..